JASON SIREL: Open Payments
NPI 1114643152 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 61 payments from 14 companies in 2025. Trend: 2023 $958 · 2024 $1,503 · 2025 $1,624
Food & beverage: $1,441Education: $183
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $481 |
| Janssen Biotech, Inc. | 7 | $292 |
| ABBVIE INC. | 19 | $272 |
| UCB, Inc. | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| Organon LLC | 5 | $67 |
| GENZYME CORPORATION | 2 | $57 |
| Amgen Inc. | 2 | $55 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: ILUMYA, TREMFYA, DUPIXENT, RINVOQ, Bimzelx, SKYRIZI, OTEZLA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
